Conditions: Congenital Bleeding Disorder Haemophilia B
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 13
Healthy volunteers: no

Brief summary:
This trial is conducted in Africa, Asia, Europe and the United States of America (USA).

The aim of the trial is to evaluate the safety and efficacy of NNC-0156-0000-0009 (nonacog beta pegol) during surgical procedures in patients with haemophilia B.

Detailed description:

Arms:
arm 1: New patients will be included as well as transferred patients from Paradigm™ 2 or Paradigm™ 4 trial

Interventions: intervention 1: nonacog beta pegol
Intervention descriptions: intervention 1: The patients will receive nonacog beta pegol at screening just prior to and during surgical intervention, administered intravenously (into the vein).

Protocol document: